Skip to main content

Diet and Weight Management

  • Chapter
  • First Online:
Chronic Illness Care

Abstract

The prevalence of obesity has increased dramatically over the past 30 years in the United States and globally. Obesity is strongly associated with incidence of and mortality due to many chronic diseases, including certain cancers, cardiovascular disease, type 2 diabetes, osteoarthritis, and obstructive sleep apnea. An unhealthy diet is a risk factor for developing obesity. This chapter reviews evidence from epidemiologic studies and clinical trials regarding the effects of diet on obesity and chronic disease outcomes. Studies that examine dietary patterns are reviewed and provide guidance in making diet recommendations to patients. Treatment of obesity and chronic diseases and dietary strategies for obesity prevention are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hu FB. Obesity epidemiology. New York: Oxford University Press; 2008.

    Book  Google Scholar 

  2. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998;280:1371–4.

    Article  CAS  PubMed  Google Scholar 

  3. Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392–404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–90.

    Article  CAS  PubMed  Google Scholar 

  5. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3):e1000252.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341–54.

    Article  CAS  PubMed  Google Scholar 

  7. Hu FB, Rimm EB, Stampfer MJ, et al. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72(4):912–21.

    Article  CAS  PubMed  Google Scholar 

  8. Moyer VA, U. S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):373–8.

    PubMed  Google Scholar 

  9. Daniels SR, Hassink SG, Committee On Nutrition. The role of the pediatrician in primary prevention of obesity. Pediatrics. 2015;136(1):e275–92.

    Article  PubMed  Google Scholar 

  10. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284–91.

    Article  CAS  PubMed  Google Scholar 

  12. Harvard TH. Chan school of public health. Obesity prevention source: adult obesity. Available from: https://www.hsph.harvard.edu/obesity-prevention-source/obesity-trends/obesity-rates-worldwide/#References. Accessed 31 Oct 2016.

  13. National Center for Health Statistics. Health, United States, 2011: with special features on socioeconomic status and health. Hyattsville: U.S. Department of Health and Human Services; 2012.

    Google Scholar 

  14. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988–1994 through 2013–2014. JAMA. 2016;315(21):2292–9.

    Article  CAS  PubMed  Google Scholar 

  16. Ogden C, Carroll M, Fryar C, et al. Prevalence of obesity among adults and youth: United States 2011–2014. NCHS data brief, no 219. Hyattsville: National Center for Health Statistics; 2015.

    Google Scholar 

  17. Malik VS, Pan A, Willett WC, et al. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98(4):1084–102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rosenheck R. Fast food consumption and increased caloric intake: a systematic review of a trajectory towards weight gain and obesity risk. Obes Rev. 2008;9(6):535–47.

    Article  CAS  PubMed  Google Scholar 

  19. Rouhani MH, Salehi-Abargouei A, Surkan PJ, et al. Is there a relationship between red or processed meat intake and obesity? A systematic review and meta-analysis of observational studies. Obes Rev. 2014;15(9):740–8.

    Article  CAS  PubMed  Google Scholar 

  20. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556–65.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sjostrom L, Gummesson A, Sjostrom CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish obese subjects study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.

    Article  PubMed  Google Scholar 

  23. Jung RT. Obesity as a disease. Br Med Bull. 1997;53(2):307–21.

    Article  CAS  PubMed  Google Scholar 

  24. Swinburn BA, Caterson I, Seidell JC, et al. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 2004;7(1A):123–46.

    CAS  PubMed  Google Scholar 

  25. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  CAS  PubMed  Google Scholar 

  27. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–9.

    Article  PubMed  Google Scholar 

  28. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    Article  CAS  PubMed  Google Scholar 

  29. Jiang L, Rong J, Wang Y, et al. The relationship between body mass index and hip osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine. 2011;78(2):150–5.

    Article  PubMed  Google Scholar 

  30. Zheng H, Chen C. Body mass index and risk of knee osteoarthritis: systematic review and meta-analysis of prospective studies. BMJ Open. 2015;5(12):e007568.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163(3 Pt 1):685–9.

    Article  CAS  PubMed  Google Scholar 

  32. Fritscher LG, Mottin CC, Canani S, et al. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes Surg. 2007;17(1):95–9.

    Article  PubMed  Google Scholar 

  33. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015–21.

    Article  CAS  PubMed  Google Scholar 

  34. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord. 2001;25(5):669–75.

    Article  CAS  PubMed  Google Scholar 

  35. Wolk R, Somers VK. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab. 2006;8(3):250–60.

    Article  CAS  PubMed  Google Scholar 

  36. Romero-Corral A, Caples SM, Lopez-Jimenez F, et al. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137(3):711–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Crook ED, Peters M. Health disparities in chronic diseases: where the money is. Am J Med Sci. 2008;335(4):266–70.

    Article  PubMed  Google Scholar 

  38. Ogden C, Lamb M, Carroll M, et al. Obesity and socioeconomic status in adults: United States 1988–1994 and 2005–2008. NCHS data brief no 50. Hyattsville: National Center for Health Statistics; 2010.

    Google Scholar 

  39. Smedley BD, Stith AY, Nelson AR. Unequal treatment: confronting racial and ethnic disparities in health care. Washington: National Academies Press; 2003.

    Google Scholar 

  40. Gerteis J, Izrael D, Deitz D, et al. Multiple chronic conditions chartbook. AHRQ publications no, Q14–0038. Rockville: Agency for Healthcare Research and Quality; 2014. Available from: http://www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/mccchartbook.pdf. Accessed 1 Nov 2016.

    Google Scholar 

  41. Finkelstein EA, Trogdon JG, Cohen JW, et al. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28(5):w822–31.

    Article  Google Scholar 

  42. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.

    Article  PubMed  Google Scholar 

  43. National Cancer Institute. Prevalence and cost of care projections. Available from: https://costprojections.cancer.gov/. Accessed 23 Dec 2013.

  44. American Diabetes Association. The cost of diabetes. Available from: http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html. Accessed 30 Oct 2016.

  45. Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hooper L, Summerbell CD, Thompson R, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev. 2012;16(5):CD002137.

    Google Scholar 

  47. Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12(8):911–9.

    Article  CAS  PubMed  Google Scholar 

  49. Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146–55.

    Article  CAS  PubMed  Google Scholar 

  50. Siri-Tarino PW, Sun Q, Hu FB, et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab. 2009;55(1–3):173–201.

    Article  CAS  PubMed  Google Scholar 

  52. US Department of Health and Human Services; US Department of Agriculture. Scientific report of the 2015 dietary guidelines advisory committee. Part D Chapter 6: cross-cutting topics of public health importance. Washington: US Dept of Health and Human Services; 2015.

    Google Scholar 

  53. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121(21):2271–83.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Fung TT, Malik V, Rexrode KM, et al. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr. 2009;89(4):1037–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Diabetes Prevention Program Research Group. The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–71.

    Article  Google Scholar 

  56. Salas-Salvado J, Bullo M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011;34(1):14–9.

    Article  PubMed  Google Scholar 

  57. Satija A, Bhupathiraju SN, Rimm EB, et al. Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies. PLoS Med. 2016;13(6):e1002039.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Sun Q, Spiegelman D, van Dam RM, et al. White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med. 2010;170(11):961–9.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Pan A, Sun Q, Bernstein AM, et al. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr. 2011;94(4):1088–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Palmer JR, Boggs DA, Krishnan S, et al. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med. 2008;168(14):1487–92.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292(8):927–34.

    Article  CAS  PubMed  Google Scholar 

  62. Willett W. Nutritional epidemiology. 3rd ed. Oxford, UK: Oxford University Press; 2013.

    Google Scholar 

  63. Toledo E, Salas-Salvado J, Donat-Vargas C, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med. 2015;175(11):1752–60.

    Article  PubMed  Google Scholar 

  64. Farvid MS, Chen WY, Michels KB, et al. Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study. BMJ. 2016;353:i2343.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Pan A, Sun Q, Bernstein AM, et al. Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med. 2012;172(7):555–63.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Lin JS, O’Connor E, Evans CV, et al. Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;161(8):568–78.

    Article  PubMed  Google Scholar 

  67. Jackson SE, Wardle J, Johnson F, et al. The impact of a health professional recommendation on weight loss attempts in overweight and obese British adults: a cross-sectional analysis. BMJ Open. 2013;3(11):e003693.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Post RE, Mainous AG 3rd, Gregorie SH, et al. The influence of physician acknowledgment of patients’ weight status on patient perceptions of overweight and obesity in the United States. Arch Intern Med. 2011;171(4):316–21.

    Article  PubMed  Google Scholar 

  69. Rose SA, Poynter PS, Anderson JW, et al. Physician weight loss advice and patient weight loss behavior change: a literature review and meta-analysis of survey data. Int J Obes. 2013;37(1):118–28.

    Article  CAS  Google Scholar 

  70. LeBlanc ES, O’Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. preventive services task force. Ann Intern Med. 2011;155(7):434–47.

    Article  PubMed  Google Scholar 

  71. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.

    Article  PubMed  Google Scholar 

  72. Fitzpatrick SL, Wischenka D, Appelhans BM, et al. An evidence-based guide for obesity treatment in primary care. Am J Med. 2016;129(1):115 e1–7.

    Article  Google Scholar 

  73. Tsai AG, Wadden TA. Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med. 2009;24(9):1073–9.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Wadden TA, Butryn ML, Hong PS, et al. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312(17):1779–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Donnelly JE, Goetz J, Gibson C, et al. Equivalent weight loss for weight management programs delivered by phone and clinic. Obesity (Silver Spring). 2013;21(10):1951–9.

    Article  Google Scholar 

  76. Perri MG, Limacher MC, Durning PE, et al. Extended-care programs for weight management in rural communities: the treatment of obesity in underserved rural settings (TOURS) randomized trial. Arch Intern Med. 2008;168(21):2347–54.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Rock CL, Flatt SW, Sherwood NE, et al. Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: a randomized controlled trial. JAMA. 2010;304(16):1803–10.

    Article  CAS  PubMed  Google Scholar 

  78. Jensen M, Ryan D, Donato K, et al. Guidelines (2013) for the managing of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S5–39.

    Google Scholar 

  79. Look Ahead Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.

    Article  CAS  Google Scholar 

  80. Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125(9):1157–70.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Ross R, Lam M, Blair SN, et al. Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. Arch Intern Med. 2012;172(5):414–24.

    Article  PubMed  Google Scholar 

  82. Christie D, Channon S. The potential for motivational interviewing to improve outcomes in the management of diabetes and obesity in paediatric and adult populations: a clinical review. Diabetes Obes Metab. 2014;16(5):381–7.

    Article  CAS  PubMed  Google Scholar 

  83. Whitlock EP, Orleans CT, Pender N, et al. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med. 2002;22:267–84.

    Article  PubMed  Google Scholar 

  84. Mitchell NS, Prochazka AV, Glasgow RE. Time to RE-AIM: why community weight loss programs should be included in academic obesity research. Prev Chronic Dis. 2016;13:E37.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Pagoto S, Schneider K, Jojic M, et al. Evidence-based strategies in weight-loss mobile apps. Am J Prev Med. 2013;45(5):576–82.

    Article  PubMed  Google Scholar 

  86. Boudreaux ED, Waring ME, Hayes RB, et al. Evaluating and selecting mobile health apps: strategies for healthcare providers and healthcare organizations. Trans Behav Med. 2014;4(4):363–71.

    Article  Google Scholar 

  87. Verheijden MW, Bakx JC, van Weel C, et al. Role of social support in lifestyle-focused weight management interventions. Eur J Clin Nutr. 2005;59(Suppl 1):S179–86.

    Article  PubMed  Google Scholar 

  88. Harvard Health Publications. Harvard health letter. Weight-loss surgery: moving into new dimensions? Available from: http://www.health.harvard.edu/staying-healthy/weight-loss-surgery-moving-into-new-dimensions. Accessed 7 Nov 2016.

  89. Kissler HJ, Settmacher U. Bariatric surgery to treat obesity. Semin Nephrol. 2013;33(1):75–89.

    Article  PubMed  Google Scholar 

  90. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.

    Article  CAS  PubMed  Google Scholar 

  91. Madura JA 2nd, Dibaise JK. Quick fix or long-term cure? Pros and cons of bariatric surgery. F1000 Med Rep. 2012;4:19.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Taylor JP, Krondl MM, Spidel M, et al. Dietary adequacy of the rotary diversified diet as a treatment for “environmental illness”. Can J Diet Pract Res. 2002;63:198–201.

    Article  PubMed  Google Scholar 

  93. Lynch CS, Chang JC, Ford AF, et al. Obese African-American women’s perspectives on weight loss and bariatric surgery. J Gen Intern Med. 2007;22(7):908–14.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Metcalf B, Rabkin RA, Rabkin JM, et al. Weight loss composition: the effects of exercise following obesity surgery as measured by bioelectrical impedance analysis. Obes Surg. 2005;15(2):183–6.

    Article  PubMed  Google Scholar 

  96. Konttinen H, Peltonen M, Sjostrom L, et al. Psychological aspects of eating behavior as predictors of 10-y weight changes after surgical and conventional treatment of severe obesity: results from the Swedish obese subjects intervention study. Am J Clin Nutr. 2015;101(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  97. King WC, Chen JY, Belle SH, et al. Change in pain and physical function following bariatric surgery for severe obesity. JAMA. 2016;315(13):1362–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Schwenk T. At 1 year after bariatric surgery, many patients have less pain and better physical function. NEJM J Watch Inf Pract. April 14, 2016. Available from: http://www.jwatch.org/na40966/2016/04/14/1-year-after-bariatric-surgery-many-patients-have-less. Accessed 3 Nov 2016.

  99. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.

    Article  CAS  PubMed  Google Scholar 

  100. Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.

    Article  Google Scholar 

  101. Giovannucci E. Obesity and cancer: epidemiologic observations. Lecture for obesity epidemiology. Boston: Harvard TH Chan School of Public Health; 2015.

    Google Scholar 

  102. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers – evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol. 2000;74(5):357–64.

    Article  CAS  PubMed  Google Scholar 

  103. Arterburn D, Bogart A, Coleman KJ, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013;7(4):e258–68.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56 e5.

    Article  PubMed  Google Scholar 

  105. Beamish AJ, Olbers T, Kelly AS, et al. Cardiovascular effects of bariatric surgery. Nat Rev Cardiol. Published online October 20, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27762312. Accessed 7 Nov 2016.

  106. Kwok CS, Pradhan A, Khan MA, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.

    Article  PubMed  Google Scholar 

  107. Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016;354:i3794.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993;119(10):1029–35.

    Article  CAS  PubMed  Google Scholar 

  109. Gustafsson U, Benthin L, Granstrom L, et al. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005;41(6):1322–8.

    Article  PubMed  Google Scholar 

  110. Li VK, Pulido N, Fajnwaks P, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2009;23(7):1640–4.

    Article  PubMed  Google Scholar 

  111. Iglezias Brandao de Oliveira C, Adami Chaim E, da Silva BB. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13(4):625–8.

    Article  PubMed  Google Scholar 

  112. King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Richardson WS, Plaisance AM, Periou L, et al. Long-term management of patients after weight loss surgery. Ochsner J. 2009;9(3):154–9.

    PubMed  PubMed Central  Google Scholar 

  114. Xanthakos SA. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin N Am. 2009;56(5):1105–21.

    Article  Google Scholar 

  115. Maciejewski ML, Arterburn DE. Cost-effectiveness of bariatric surgery. JAMA. 2013;310(7):742–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Fujioka K. Current and emerging medications for overweight or obesity in people with comorbidities. Diabetes Obes Metab. 2015;17(11):1021–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. American Association of Diabetes Educators. Practice adivisory: weight loss medications (Issued August 16, 2013). Available from: https://www.diabeteseducator.org/docs/default-source/legacy-docs/_resources/pdf/research/weightlossmedications_practice_advisory_final.pdf?sfvrsn=2. Accessed 1 Nov 2016.

  118. Tsai SA, Lv N, Xiao L, et al. Gender differences in weight-related attitudes and behaviors among overweight and obese adults in the United States. Am J Mens Health. 2016;10(5):389–98.

    Article  PubMed  Google Scholar 

  119. Finkelstein EA, Kruger E. Meta- and cost-effectiveness analysis of commercial weight loss strategies. Obesity. 2014;22(9):1942–51.

    Article  PubMed  Google Scholar 

  120. Riser Taylor S, Harris KB. The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus. Pharmacotherapy. 2013;33(9):984–99.

    Article  CAS  PubMed  Google Scholar 

  121. Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.

    Article  CAS  PubMed  Google Scholar 

  122. US Food and Drug Administration. Xenical prescription information (Revised 10/2013). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020766s033lbl.pdf. Accessed 21 Oct 2016.

  123. US Food and Drug Administration. Qsymia® Prescription information (Revised 04/2013). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022580s004lbl.pdf. Accessed 21 Oct 2016.

  124. US Food and Drug Administration. BELVIQ Prescription information (Revised: 06/2012). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022529lbl.pdf. Accessed 21 Oct 2016.

  125. US Food and Drug Administration. Contrave® Prescription information (Revised: 09/2014). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/200063s000lbl.pdf. Accessed 21 Oct 2016.

  126. van Can J, Sloth B, Jensen CB, et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes. 2014;38(6):784–93.

    Article  CAS  Google Scholar 

  127. European Medicines Agency. Saxenda® summary of product characteristics (2015). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003780/WC500185786.pdf. Accessed 21 Oct 2016.

  128. US Food and Drug Administration. Ionamin® capsules (phentermine resin), CIV (Revised 12/2012). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/011613s027lbl.pdf Accessed 8 Nov 2016.

  129. Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Gupta S, Wang Z. Treatment satisfaction with different weight loss methods among respondents with obesity. Clin Obes. 2016;6(2):161–70.

    Article  CAS  PubMed  Google Scholar 

  131. Nicklas JM, Huskey KW, Davis RB, et al. Successful weight loss among obese U.S. adults. Am J Prev Med. 2012;42(5):481–5.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Thomas EL, Makwana A, Newbould R, et al. Pragmatic study of orlistat 60 mg on abdominal obesity. Eur J Clin Nutr. 2011;65(11):1256–62.

    Article  CAS  PubMed  Google Scholar 

  133. Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330–42.

    Article  CAS  Google Scholar 

  134. Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–52.

    Article  CAS  PubMed  Google Scholar 

  135. Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297–308.

    Article  CAS  PubMed  Google Scholar 

  136. Fidler MC, Sanchez M, Raether B, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  137. Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.

    Article  CAS  PubMed  Google Scholar 

  138. Hollander P, Gupta AK, Plodkowski R, et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. US Food and Drug Administration. Saxenda® prescription information (Revised 01/2015). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206321s001lbl.pdf. Accessed 21 Oct 2016.

  140. Wadden TA, Hollander P, Klein S, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study. Int J Obes. 2013;37(11):1443–51.

    Article  CAS  Google Scholar 

  141. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142(7):532–46.

    Article  CAS  PubMed  Google Scholar 

  142. Hu FB. The Mediterranean diet and mortality–olive oil and beyond. N Engl J Med. 2003;348(26):2595–6.

    Article  PubMed  Google Scholar 

  143. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation. 2011;123(24):2870–91.

    Article  PubMed  Google Scholar 

  144. Park Y, Subar AF, Hollenbeck A, et al. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med. 2011;171(12):1061–8.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Wang X, Ouyang Y, Liu J, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Haring B, Crandall CJ, Wu C, et al. Dietary patterns and fractures in postmenopausal women: results from the women’s health initiative. JAMA Intern Med. 2016;176(5):645–52.

    Article  PubMed  Google Scholar 

  147. Knight A, Bryan J, Wilson C, et al. A randomised controlled intervention trial evaluating the efficacy of a Mediterranean dietary pattern on cognitive function and psychological wellbeing in healthy older adults: the MedLey study. BMC Geriatr. 2015;15:55.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Petersson SD, Philippou E. Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence. Adv Nutr. 2016;7(5):889–904.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Valls-Pedret C, Sala-Vila A, Serra-Mir M, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094–103.

    Article  PubMed  Google Scholar 

  150. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the women’s health initiative randomized controlled dietary modification trial. JAMA. 2006;295(6):655–66.

    Article  CAS  PubMed  Google Scholar 

  151. Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014;312(9):923–33.

    Article  PubMed  CAS  Google Scholar 

  152. American Heart Association. Cardiovascular disease & diabetes. Available from: http://www.heart.org/HEARTORG/Conditions/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp/#.WCIo5tUrKUl. Accessed 6 Nov 2016.

  153. Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (action for health in diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610–28.

    Article  PubMed  Google Scholar 

  154. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 2016;4(8):666–76.

    Article  CAS  PubMed  Google Scholar 

  155. American Diabetes Association. Foundations of care and comprehensive medical evaluation. Sec. 3 in standards of medical care in diabetes–2016. Diabetes Care. 2016;39(Suppl 1):S23–35.

    Google Scholar 

  156. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359(3):229–41.

    Article  CAS  PubMed  Google Scholar 

  157. American Diabetes Association. Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization. Sec. 4 in standards of medical care in diabetes – 2015. Diabetes Care. 2015;38(Suppl. 1):S20–30.

    Article  Google Scholar 

  158. Hartmann-Boyce J, Johns DJ, Jebb SA, et al. Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis. Obes Rev. 2014;15(11):920–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Booth HP, Prevost TA, Wright AJ, et al. Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis. Fam Pract. 2014;31(6):643–53.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leah Elizabeth Chapman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chapman, L.E., Alexander, R., Keyserling, T.C., Ammerman, A.S. (2018). Diet and Weight Management. In: Daaleman, T., Helton, M. (eds) Chronic Illness Care. Springer, Cham. https://doi.org/10.1007/978-3-319-71812-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71812-5_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71811-8

  • Online ISBN: 978-3-319-71812-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics